- Home
- NNOX
NNOX
NANO-X IMAGING LTD
as 12-20-2024 4:00pm EST
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.
| Founded: | 2018 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 358.0M | IPO Year: | 2020 |
| Target Price: | $12.00 | AVG Volume (30 days): | 4.5M |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.26 - $14.28 | Next Earning Date: | 11-21-2024 |
| Revenue: | $10,680,000 | Revenue Growth: | 10.79% |
| Revenue Growth (this year): | 33.22% | Revenue Growth (next year): | 236.15% |
Latest NANO-X IMAGING LTD News
NNOX Breaking Stock News: Dive into NNOX Ticker-Specific Updates for Smart Investing
TipRanks
16 days ago
Nano-X Imaging Expands FDA Clearance for Nanox.ARC
MT Newswires
17 days ago
Sector Update: Health Care Stocks Decline Thursday Afternoon
Exec Edge
17 days ago
Nanox.ARC Gets FDA Clearance for Expanded Diagnostic Imaging
Motley Fool
17 days ago
Here's Why Nanox Stock Went Up Today
MT Newswires
17 days ago
Sector Update: Health Care Stocks Mixed Premarket Thursday
MT Newswires
17 days ago
Sector Update: Health Care
MT Newswires
17 days ago
Nano-X Imaging Receives FDA Clearance for Nanox.ARC X-ray System
GlobeNewswire
17 days ago
Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication
Compare NNOX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NNOX NANO-X IMAGING LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.